VVOS News and Press, Vivos Therapeutics Inc. From 03/08/23

LITTLETON, Colo., March 08, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS) , a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment...

Vivos Therapeutics (NASDAQ: VVOS) , a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment of breathing related sleep disorders, today announced its acquisition of certain U.S. and international patents, pro...

Vivos Therapeutics ( NASDAQ: VVOS ) acquired certain U.S. and international patents, product rights, and other intellectual property (IP) from Advanced Facialdontics (AFD). Vivos said AFD's main product, Preventive Oral Device, known as the POD, has FDA 510(k) clearance to treat patie...

LITTLETON, Colo., March 01, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS) , a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treat...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now’s a great time to start considering which micro-cap stocks to buy. Generally, micro-caps are stocks with a market capitalization of less than $300 million. With a cap like that, the company doesn’t have a to...

Vivos Therapeutics (NASDAQ: VVOS) is focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The company today announced its receipt of a notice from the listing...

Vivos Therapeutics ( NASDAQ: VVOS ) said it regained compliance with Nasdaq's rule of $1 minimum bid price requirement for continued listing on the exchnage. Vivos was previously notified by Nasdaq on Nov. 3, 2022 that it was not in compliance with the minimum bid price rule becau...

LITTLETON, Colo., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obst...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has closed on its previously announced private placement....

LITTLETON, Colo., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obst...